<SEC-DOCUMENT>0001140361-23-050598.txt : 20231101
<SEC-HEADER>0001140361-23-050598.hdr.sgml : 20231101
<ACCEPTANCE-DATETIME>20231101060254
ACCESSION NUMBER:		0001140361-23-050598
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20231101
FILED AS OF DATE:		20231101
DATE AS OF CHANGE:		20231101

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IPERIONX Ltd
		CENTRAL INDEX KEY:			0001898601
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS METAL ORES [1090]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			C3
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41338
		FILM NUMBER:		231366393

	BUSINESS ADDRESS:	
		STREET 1:		129 W TRADE STREET
		STREET 2:		SUITE 1405
		CITY:			CHARLOTTE
		STATE:			NC
		ZIP:			28202
		BUSINESS PHONE:		7045783217

	MAIL ADDRESS:	
		STREET 1:		129 W TRADE STREET
		STREET 2:		SUITE 1405
		CITY:			CHARLOTTE
		STATE:			NC
		ZIP:			28202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Hyperion Metals Ltd
		DATE OF NAME CHANGE:	20211210
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ef20013803_6k.htm
<DESCRIPTION>6-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc
         Document created using Broadridge PROfile 23.9.1.5178
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div style="text-align: center; font-size: 14pt; font-weight: bold;">UNITED STATES</div>
      <div style="text-align: center; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
      <div style="text-align: center; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-weight: bold;">
        <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000;"></div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-size: 18pt; font-weight: bold;">FORM 6-K</div>
      <div style="text-align: center; font-weight: bold;"><br>
      </div>
      <div style="text-align: center; font-weight: bold;">
        <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000;">
        <div><br>
        </div>
      </div>
      <div style="text-align: center; font-weight: bold;">REPORT OF FOREIGN PRIVATE ISSUER</div>
      <div style="text-align: center; font-weight: bold;">Pursuant to Rule 13a-16 or 15d-16 of the</div>
      <div style="text-align: center; font-weight: bold;">Securities Exchange Act of 1934</div>
      <div><br>
      </div>
      <div style="text-align: center; font-weight: bold;">Date: November 1, 2023</div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-size: 12pt;"><font style="font-size: 10pt; font-weight: bold;">Commission File Number:</font><font style="font-size: 10pt;">&#160;<font style="font-weight: bold;">001-41338</font></font></div>
      <div style="text-align: center; font-weight: bold;"><br>
      </div>
      <div style="text-align: center; font-weight: bold;">
        <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000;"></div>
      <div style="font-weight: 400;"> <br>
      </div>
      <div style="text-align: center; font-weight: bold;"><font style="font-size: 24pt;">IperionX Limited</font></div>
      <div style="text-align: center; font-weight: bold;">(Translation of registrant&#8217;s name into English)</div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-weight: bold;">
        <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000;"></div>
      <div style="text-align: center; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-weight: bold;">129 W Trade Street, Suite 1405</div>
      <div style="text-align: center; font-weight: bold;">Charlotte, North Carolina</div>
      <div style="text-align: center; font-weight: bold;">(Address of principal executive offices)</div>
      <div style="text-align: center; font-weight: bold;"><br>
      </div>
      <div style="text-align: center; font-weight: bold;">
        <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 20%; color: #000000;"></div>
      <div style="text-indent: 36pt;"> <br>
      </div>
      <div style="text-indent: 36pt;">Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</div>
      <div><br>
      </div>
      <div style="text-indent: 108pt; font-size: 14pt;"><font style="font-size: 10pt;">Form 20-F &#9746;&#160; &#160; Form 40-F &#9744;</font></div>
      <div><br>
      </div>
      <div>
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">EXHIBIT INDEX</div>
      <div>The following exhibits are filed as part of this Form 6-K:</div>
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z7280aa02026a4b4a9786382a9354aff4" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 7%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center;">Exhibit</div>
            </td>
            <td style="width: 5%; vertical-align: bottom;">&#160;</td>
            <td style="width: 88%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>Description</div>
            </td>
          </tr>
          <tr>
            <td style="width: 7%; vertical-align: bottom;">&#160;</td>
            <td style="vertical-align: bottom;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 7%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div><a href="ef20013803_ex99-1.htm">99.1</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
            <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div>Press Release</div>
            </td>
          </tr>
          <tr>
            <td style="width: 7%; vertical-align: top;">
              <div><a href="ef20013803_ex99-2.htm">99.2</a></div>
            </td>
            <td style="width: 5%; vertical-align: top;">&#160;</td>
            <td style="width: 88%; vertical-align: top;">
              <div>Press Release</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-weight: bold;">SIGNATURE</div>
      <div style="text-align: center;"> <br>
      </div>
      <div>Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</div>
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z44e2d04e426f455ab83203b60f37d0e3" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: bottom;">&#160;</td>
            <td style="width: 3%; vertical-align: bottom;" colspan="2" rowspan="1">
              <div>IPERIONX LIMITED</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: bottom;">&#160;</td>
            <td style="width: 3%; vertical-align: bottom;" colspan="2" rowspan="1">
              <div>(registrant)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: bottom;">&#160;</td>
            <td style="width: 3%; vertical-align: bottom;" colspan="1">&#160;</td>
            <td style="width: 47.04%; vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: bottom;">
              <div>Date: November 1, 2023</div>
            </td>
            <td style="width: 3%; vertical-align: bottom;" colspan="1">By: <br>
            </td>
            <td style="width: 47.04%; vertical-align: bottom;">
              <div><u>/s/ Gregory Swan</u><br>
              </div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: bottom;">&#160;</td>
            <td style="width: 5%; vertical-align: bottom;" colspan="1">Name:</td>
            <td style="width: 45%; vertical-align: bottom;">
              <div>Gregory Swan</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: bottom;">&#160;</td>
            <td style="width: 5%; vertical-align: bottom;" colspan="1">Title: <br>
            </td>
            <td style="width: 45%; vertical-align: bottom;">
              <div>Chief Financial Officer</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div><br>
      </div>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ef20013803_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc
         Document created using Broadridge PROfile 23.9.1.5178
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 99.1</font><br>
      </div>
      <div>
        <div><br>
        </div>
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="z49af2d3acc694c3a8d1698b8863e74f5">

              <tr>
                <td style="width: 50%;"><img src="image01.jpg"></td>
                <td style="width: 50.00%;">
                  <div style="color: rgb(0, 37, 84);">
                    <div style="text-align: right;"><font style="font-weight: bold;">PRESS RELEASE</font> | NASDAQ: IPX | ASX: IPX</div>
                    <div>
                      <div style="text-align: right; font-style: italic;">November 1, 2023</div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
        <div><br>
        </div>
        <div style="text-align: center; font-style: italic; font-weight: bold;">IPERIONX RECEIVES US$12.7M U.S. DEPARTMENT OF DEFENSE GRANT FOR DOMESTIC TITANIUM PRODUCTION</div>
        <div>&#160;</div>
        <div style="text-align: justify; font-style: normal; font-weight: bold;">IperionX Limited (IperionX) (NASDAQ: IPX, ASX: IPX) <font style="font-weight: normal;">is pleased to announce that the U.S. Department of Defense (U.S. DoD) has advised that
            it has contracted to award IperionX US$12.7 million in funding awarded under the Defense Production Act (DPA) Title III authorities to address U.S. titanium supply chain vulnerabilities.</font></div>
        <font style="font-style: italic;"> <font style="font-weight: normal;"> </font> </font>
        <div style="font-weight: normal; font-style: italic;">&#160;</div>
        <font style="font-style: italic;"> <font style="font-weight: normal;"> </font> </font>
        <div style="text-align: justify; font-style: normal; font-weight: normal;">The combination of the non-dilutive US$12.7 million U.S. DoD grant and the potential for a further US$11.5 million in equipment financing under the previously announced
          Export-Import Bank of the United States ("EXIM Bank") initiatives provide an outstanding platform for IperionX to accelerate the re-shoring of U.S. domestic titanium production through the development of its titanium production facility in
          Halifax County, Virginia.</div>
        <font style="font-style: normal;"> <font style="font-weight: normal;"> </font> </font>
        <div style="font-weight: normal; font-style: normal;">&#160;</div>
        <font style="font-style: normal;"> <font style="font-weight: normal;"> </font> </font>
        <div style="text-align: justify; font-style: normal; font-weight: normal;">The U.S. DoD has undertaken extensive due diligence of IperionX&#8217;s titanium metal technologies through the application and contracting process, including U.S. DoD
          representatives undertaking a site visit to IperionX&#8217;s operating pilot plant in Utah.</div>
        <font style="font-style: normal;"> <font style="font-weight: normal;"> </font> </font>
        <div style="font-weight: normal; font-style: normal;">&#160;</div>
        <font style="font-style: normal;"> <font style="font-weight: normal;"> </font> </font>
        <div style="text-align: justify; font-style: normal; font-weight: normal;">The United States has limited domestic primary titanium metal (titanium sponge) capacity and currently imports over 95% of the titanium sponge required for the U.S. defense
          sector. IperionX intends to re-shore a full titanium supply chain to the U.S. to reduce the acute reliance on titanium imports from foreign nations and strengthen the titanium supply chain for critical defense and advanced industries. </div>
        <font style="font-style: normal;"> <font style="font-weight: normal;"> </font> </font>
        <div style="font-weight: normal; font-style: normal;">&#160;</div>
        <font style="font-style: normal;"> <font style="font-weight: normal;"> </font> </font>
        <div style="text-align: justify; font-style: normal; font-weight: normal;">IperionX will apply the US$12.7 million U.S. DoD grant funding towards building a 125 metric tons per annum titanium production facility in Halifax County, Virginia, with
          first production expected in 2024. Once commissioned, IperionX intends to rapidly scale the capacity of this advanced titanium production facility &#8211; in a modular development approach &#8211; to 1,125 metric tons per annum on the same site in Virginia.
        </div>
        <font style="font-style: normal;"> </font>
        <div style="font-style: normal;">&#160;</div>
        <font style="font-style: normal;"> <font style="font-weight: normal;"> </font> </font>
        <div style="text-align: justify; font-style: normal; font-weight: normal;">Titanium has been mass produced in the same way since the 1940s when the existing &#8216;Kroll Process&#8217; was developed. The Kroll Process is energy intensive, high cost and
          produces high levels of greenhouse gas emissions. In contrast, IperionX&#8217;s titanium production technologies use less energy to produce high-strength titanium, at lower costs, with zero Scope 1 and 2 emissions. </div>
        <font style="font-style: normal;"> <font style="font-weight: normal;"> </font> </font>
        <div style="font-weight: normal; font-style: normal;">&#160;</div>
        <font style="font-style: normal;"> <font style="font-weight: normal;"> </font> </font>
        <div style="text-align: justify; font-style: normal; font-weight: normal;">Titanium is prized for its high strength-to-weight ratio, resistance to high temperatures and corrosion. Titanium is a critical material for many U.S. defense systems and
          for a range of demanding applications in the aerospace, space, medical, consumer electronics, additive manufacturing, hydrogen and automotive sectors.</div>
        <font style="font-style: normal;"> <font style="font-weight: normal;"> </font> </font>
        <div style="font-weight: normal; font-style: normal;">&#160;</div>
        <font style="font-style: normal;"> <font style="font-weight: normal;"> </font> </font>
        <div style="text-align: justify; font-style: normal; font-weight: normal;">IperionX has the potential to deliver a full U.S. titanium supply chain from titanium mineral production to the manufacturing of high performance titanium products, and the
          unique ability to use 100% recycled scrap titanium. IperionX can produce a wide range of titanium products - including titanium powder, ingots, bars, and plate &#8211; at higher energy efficiency, lower costs, and with lower environmental impacts. </div>
        <font style="font-style: normal;"> <font style="font-weight: normal;"> </font> </font>
        <div style="font-weight: normal; font-style: normal;">&#160;</div>
        <font style="font-style: normal;"> <font style="font-weight: normal;"> </font> </font>
        <div style="text-align: justify; font-style: normal; font-weight: normal;">The US$12.7 million U.S. DoD grant will be matched on a 1:1 cost share basis by IperionX, for a total funding amount of ~US$25 million. Further details can be found in
          Appendix 1.</div>
        <div>&#160;</div>
        <div style="text-align: justify; font-weight: bold;">Dr. Laura Taylor-Kale, Assistant Secretary of Defense for Industrial Base Policy said:</div>
        <div>&#160;</div>
        <div style="text-align: justify;">&#8220;Titanium is critical to the basic Warfighting capability of the United States. Domestic titanium production is a top priority for the DoD&#8217;s industrial base programs.&#8221;</div>
        <div>&#160;</div>
        <div style="text-align: justify; font-weight: bold;">Anastasios (Taso) Arima, IperionX CEO said: </div>
        <div>&#160;</div>
        <div style="text-align: justify;">&#8220;Titanium for the U.S. defense sector is currently sourced over long distances from foreign nations. We are pleased to receive this award from the U.S. DoD that will assist IperionX to re-shore a lower-cost, more
          sustainable and fully integrated U.S. titanium supply chain that is critical to America&#8217;s national security.&#8221; </div>
        <div>&#160;</div>
        <div>
          <table cellspacing="0" cellpadding="0" border="0" id="z01df3e40ff8646599859317b9abdf095" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 25%; vertical-align: middle;">
                  <div style="text-align: justify; font-weight: bold;">North Carolina</div>
                </td>
                <td style="width: 25%; vertical-align: middle;">
                  <div style="text-align: justify; font-weight: bold;">Tennessee</div>
                </td>
                <td style="width: 25%; vertical-align: middle;">
                  <div style="text-align: justify; font-weight: bold;">Virginia</div>
                </td>
                <td style="width: 25%; vertical-align: middle;">
                  <div style="text-align: justify; font-weight: bold;">Utah</div>
                </td>
              </tr>
              <tr>
                <td style="width: 25%; vertical-align: middle;">
                  <div style="text-align: justify;">129 W Trade Street, Suite 1405</div>
                  <div style="text-align: justify;">Charlotte, NC 28202</div>
                </td>
                <td style="width: 25%; vertical-align: middle;">
                  <div style="text-align: justify; text-indent: -180pt; margin-left: 180pt;">279 West Main Street</div>
                  <div style="text-align: justify; text-indent: -180pt; margin-left: 180pt;">Camden, TN 38320</div>
                </td>
                <td style="width: 25%; vertical-align: middle;">
                  <div style="text-align: justify; text-indent: -180pt; margin-left: 180pt;">1080 Confroy Drive</div>
                  <div style="text-align: justify; text-indent: -180pt; margin-left: 180pt;">South Boston, VA 24592</div>
                </td>
                <td style="width: 25%; vertical-align: middle;">
                  <div style="text-align: justify;">1782 W 2300 S</div>
                  <div style="text-align: justify;">West Valley City, UT 84119</div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: center;"><img src="image02.jpg"></div>
        <div style="text-align: center; font-style: italic; font-weight: bold;">IperionX&#8217;s titanium production facility, Virginia.</div>
        <div>&#160;</div>
        <div style="text-align: justify; font-style: normal; font-weight: normal;">This announcement has been authorized for release by the CEO and Managing Director. </div>
        <div>&#160;</div>
        <div style="text-align: justify; font-style: normal; font-weight: normal;">For further information and enquiries please contact:</div>
        <div>&#160;</div>
        <div style="text-align: justify; font-style: normal; font-weight: bold;">info@iperionx.com</div>
        <font style="font-style: normal;"> </font>
        <div style="text-align: justify; font-style: normal; font-weight: bold;">+1 704 461 8000</div>
        <div>&#160;</div>
        <div style="font-weight: bold;">About the Department of Defense's Office of the Assistant Secretary of Defense for Industrial Base Policy:</div>
        <div>&#160;</div>
        <div style="text-align: justify;">The Assistant Secretary of Defense for Industrial Base Policy is the principal advisor to the Under Secretary of Defense for Acquisition and Sustainment (USD(A&amp;S)) for developing Department of Defense policies
          for the maintenance of the United States defense industrial base (DIB), executing small business programs and policy, and conduction geo-economic analysis and assessments.&#160; </div>
        <div>&#160;</div>
        <div style="text-align: justify;">The office also provides the USD(A&amp;S) with recommendations on budget matters related to the DIB, anticipates and closes gaps in manufacturing capabilities for defense systems, and assesses impacts related to
          mergers, acquisition, and divestitures.&#160; IBP monitors and assesses the impact of foreign investments in the United States and executes authorities under sections 2501 and 2505 U.S.C. Title 10. </div>
        <div>&#160;</div>
        <div style="text-align: justify; font-weight: bold;">About IperionX </div>
        <div>&#160;</div>
        <div style="text-align: justify;">IperionX aims to become a leading American titanium metal and critical materials company &#8211; using patented metal technologies to produce high performance titanium alloys, from titanium minerals or scrap titanium, at
          lower energy, cost and carbon emissions. </div>
        <div>&#160;</div>
        <div style="text-align: justify;">Our Titan critical minerals project is the largest JORC-compliant mineral resource of titanium, rare earth and zircon minerals sands in the United States. </div>
        <div>&#160;</div>
        <div style="text-align: justify;">IperionX&#8217;s titanium metal and critical minerals are essential for advanced U.S. industries including space, aerospace, defense, consumer electronics, hydrogen, electric vehicles and additive manufacturing. </div>
        <div>&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: justify; font-weight: bold;">Appendix I: U.S. Department of Defense Grant Funding</div>
        <div>&#160;</div>
        <div>IperionX and the Government of the United States have entered into a Technology Investment Agreement (&#8220;TIA&#8221;) issued under the authority of 10 U.S.C. 4001 and Title III of the Defense Production Act of 1950, for <font style="font-style: italic;">&#8220;Scale Up Funding for Sustainable and Low-Cost Titanium Technology to Re-shore U.S. Titanium Metal Production&#8221;</font>.</div>
        <div>&#160;</div>
        <div style="text-align: justify;">The total amount of the agreement is US$26.1 million, with a U.S. Government&#8217;s share of US$12.7 million, and IperionX&#8217;s share of US$13.4 million.</div>
        <div>&#160;</div>
        <div style="text-align: justify;">The term of the TIA is 39 months, which may be terminated by either party upon 30 days written notice to the other party, with funding provided under the TIA is to be applied to real property or equipment. </div>
        <div>&#160;</div>
        <div>
          <div style="text-align: justify;">Title to all real property and equipment purchased with federal funds under the TIA is held by the Government through the term of the agreement, and the Government may elect to transfer title to all (or some) of
            the real property or equipment to IperionX at the end of the agreement.</div>
        </div>
        <div> <br>
        </div>
        <table cellspacing="0" cellpadding="0" id="zd0fb84bec86b4fd19f2a34e5f1f6049f" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="background-color: #D9D9D9; border-bottom: 2px solid #000000; border-left: 2px solid #000000; border-right: 2px solid #000000; border-top: 2px solid #000000; vertical-align: top; width: 100%;">
                <div style="margin: 0px 0px 0px 6pt; font-style: italic; font-weight: bold; text-align: justify;">Forward Looking Statements</div>
                <div>
                  <div>&#160;</div>
                  <div style="margin: 0px 6pt; font-style: italic; font-weight: normal; text-align: justify;">Information included in this release constitutes forward-looking statements. Often, but not always, forward looking statements can generally be
                    identified by the use of forward-looking words such as &#8220;may&#8221;, &#8220;will&#8221;, &#8220;expect&#8221;, &#8220;intend&#8221;, &#8220;plan&#8221;, &#8220;estimate&#8221;, &#8220;anticipate&#8221;, &#8220;continue&#8221;, and &#8220;guidance&#8221;, or other similar words and may include, without limitation, statements regarding
                    plans, strategies and objectives of management, anticipated production or construction commencement dates and expected costs or production outputs. </div>
                  <div style="text-align: justify; color: rgb(111, 114, 113); font-style: italic;"> <br>
                  </div>
                  <div style="margin: 0px 6pt; font-style: italic; font-weight: normal; text-align: justify;">Forward looking statements inherently involve known and unknown risks, uncertainties and other factors that may cause the Company&#8217;s actual
                    results, performance, and achievements to differ materially from any future results, performance, or achievements. Relevant factors may include, but are not limited to, changes in commodity prices, foreign exchange fluctuations and
                    general economic conditions, increased costs and demand for production inputs, the speculative nature of exploration and project development, including the risks of obtaining necessary licenses and permits and diminishing quantities or
                    grades of reserves, the Company&#8217;s ability to comply with the relevant contractual terms to access the technologies, commercially scale its closed-loop titanium production processes, or protect its intellectual property rights, political
                    and social risks, changes to the regulatory framework within which the Company operates or may in the future operate, environmental conditions including extreme weather conditions, recruitment and retention of personnel, industrial
                    relations issues and litigation.</div>
                  <div style="text-align: justify; color: rgb(111, 114, 113); font-style: italic;"> <br>
                  </div>
                  <div style="margin: 0px 6pt; font-style: italic; font-weight: normal; text-align: justify;">Forward looking statements are based on the Company and its management&#8217;s good faith assumptions relating to the financial, market, regulatory and
                    other relevant environments that will exist and affect the Company&#8217;s business and operations in the future. The Company does not give any assurance that the assumptions on which forward looking statements are based will prove to be
                    correct, or that the Company&#8217;s business or operations will not be affected in any material manner by these or other factors not foreseen or foreseeable by the Company or management or beyond the Company&#8217;s control.</div>
                  <div>&#160;</div>
                </div>
                <div style="margin: 0px 6pt; font-style: italic; font-weight: normal; text-align: justify;">Although the Company attempts and has attempted to identify factors that would cause actual actions, events or results to differ materially from
                  those disclosed in forward looking statements, there may be other factors that could cause actual results, performance, achievements, or events not to be as anticipated, estimated or intended, and many events are beyond the reasonable
                  control of the Company. Accordingly, readers are cautioned not to place undue reliance on forward looking statements. Forward looking statements in these materials speak only at the date of issue. Subject to any continuing obligations
                  under applicable law or any relevant stock exchange listing rules, in providing this information the Company does not undertake any obligation to publicly update or revise any of the forward-looking statements or to advise of any change
                  in events, conditions or circumstances on which any such statement is based.</div>
                <div style="margin: 0px 6pt; font-style: italic; font-weight: normal; text-align: justify;"> <br>
                </div>
              </td>
            </tr>

        </table>
        <div style="text-align: justify; color: #161616;"><br>
        </div>
        <div>&#160;</div>
      </div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>ef20013803_ex99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc
         Document created using Broadridge PROfile 23.9.1.5178
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 99.2</font><br>
    </div>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="z4b21a45f3b2c46ef9d0f52efde82cc5a">

          <tr>
            <td style="width: 50%;">
              <div><img src="image01.jpg"></div>
            </td>
            <td style="width: 50.00%;">
              <div>
                <div style="text-align: right; color: rgb(0, 37, 84);"><font style="font-weight: bold;">PRESS RELEASE</font> | NASDAQ: IPX | ASX: IPX</div>
                <div>
                  <div style="text-align: right; font-style: italic;">November 1, 2023</div>
                </div>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <div style="text-align: center; font-style: italic;">Not for release to US wire services or distribution in the United States</div>
      <div>&#160;</div>
      <div style="text-align: center; font-style: normal; font-weight: bold;">IPERIONX COMPLETES US$16.7M PLACEMENT TO RE-SHORE U.S. TITANIUM PRODUCTION</div>
      <div>&#160;</div>
      <div style="text-align: justify; font-style: normal; font-weight: bold;">IperionX Limited (IperionX) (NASDAQ: IPX, ASX: IPX) <font style="font-weight: normal;">is pleased to announce that it has received firm commitments for a placement of 21
          million new fully paid ordinary shares at an issue price of A$1.25 per share (&#8220;New Shares&#8221;) to existing institutional investors to raise gross proceeds of A$26.3 million (approximately US$16.7 million) before costs (&#8220;Placement&#8221;).</font></div>
      <div>&#160;</div>
      <div style="text-align: justify;">The Placement was led by existing shareholders, B Riley Principal Investments, <font style="font-weight: bold; font-style: italic;">Fidelity International, Inherent Group</font>, and one of the world&#8217;s largest asset
        managers, confirming their support for IperionX&#8217;s plans to re-shore U.S. titanium production, scale IperionX&#8217;s patented titanium technologies, advance the Titan Critical Mineral Project and for general corporate purposes. </div>
      <div>&#160;</div>
      <div style="text-align: justify;">IperionX&#8217;s technology and patent portfolio advisor, Mr. Ray Nimrod, participated in the placement, and is a significant long-term shareholder and advisor to the Company. Ray is a renowned expert in technology patent
        law, representing a range of leading technology clients, including multiple Fortune 100 companies.&#160; </div>
      <div>&#160;</div>
      <div style="text-align: justify; font-style: italic; font-weight: bold;"><font style="font-weight: normal; font-style: normal;">T<font style="font-weight: normal;">he </font>issue price of A$1.25 per New Share represents a 14.5% premium to the 5-day
          VWAP and a 3.2% discount to the 30-day VWAP. The Company expects to issue the Placement shares on or about November 3, 2023, and will issue the shares under ASX Listing Rule 7.1.</font></div>
      <div style="font-weight: normal;">&#160;</div>
      <div style="text-align: justify; font-style: normal; font-weight: normal;">IperionX has significantly bolstered its capital position with up to US$40.9 million in new funding, made up of:</div>
      <div style="font-weight: normal;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zd77675d9dbd74b6c8a1f64c66aa6cd88" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-weight: normal; font-style: normal;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-style: normal; font-weight: normal;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-weight: normal; font-style: normal;">
              <div>US$12.7 million grant from U.S. Department of Defense;</div>
            </td>
          </tr>

      </table>
      <div style="font-weight: normal; font-style: normal;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z3b471b944cb0450894c2b6879062ee45" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-weight: normal; font-style: normal;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-style: normal; font-weight: normal;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-weight: normal; font-style: normal;">
              <div>US$16.7 million from the equity Placement; and </div>
            </td>
          </tr>

      </table>
      <div style="font-weight: normal; font-style: normal;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z45719cb9f0374c74a154d7c5d2fb4991" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-weight: normal; font-style: normal;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-style: normal; font-weight: normal;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-weight: normal; font-style: normal;">
              <div>Potential for US$11.5 million in equipment financing from the Export-Import Bank of the United States ("EXIM Bank") &#8216;China and Transformational Exports Program&#8217; and &#8216;Make More in America Initiative&#8217;.</div>
            </td>
          </tr>

      </table>
      <div style="font-weight: normal; font-style: normal;">&#160;</div>
      <div style="text-align: justify; font-style: normal; font-weight: normal;">This robust financial position provides a strong platform for IperionX to accelerate plans to re-shore U.S. titanium production with the development of the advanced Titanium
        Production Facility in Halifax County, Virginia.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: -21.6pt; margin-left: 21.6pt; font-style: normal; font-weight: normal;">Bell Potter Securities Limited acted as Lead Manager to the Placement.</div>
      <div style="font-style: normal; font-weight: normal;">&#160;</div>
      <div style="text-align: justify; font-style: normal; font-weight: normal;">This announcement has been authorized for release by the Board of Directors. </div>
      <div style="font-style: normal; font-weight: normal;">&#160;</div>
      <div style="text-align: justify; font-style: normal; font-weight: normal;">For further information and enquiries please contact:</div>
      <div style="font-style: italic;">&#160;</div>
      <div style="text-align: justify; font-style: normal; font-weight: bold;">info@iperionx.com</div>
      <div style="text-align: justify; font-style: normal; font-weight: bold;">+1 704 461 8000</div>
      <div>&#160;</div>
      <div style="text-align: justify; font-style: italic; font-weight: bold;">Not an offer in the United States</div>
      <div>&#160;</div>
      <div style="text-align: justify; font-style: normal; font-weight: normal;">This announcement has been prepared for publication in Australia and may not be released to US wire services or distributed in the United States. This announcement does not
        constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States or any other jurisdiction. Any securities described in this announcement have not been, and will not be, registered under the US Securities Act of
        1933 and may not be offered or sold in the United States except in transactions exempt from, or not subject to, the registration requirements of the US Securities Act and applicable US state securities laws.</div>
      <div>&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" id="z9b5a51c2fb224a78834042ac06163222" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 25%; vertical-align: middle;">
                <div style="text-align: justify; font-weight: bold;">North Carolina</div>
              </td>
              <td style="width: 25%; vertical-align: middle;">
                <div style="text-align: justify; font-weight: bold;">Tennessee</div>
              </td>
              <td style="width: 25%; vertical-align: middle;">
                <div style="text-align: justify; font-weight: bold;">Virginia</div>
              </td>
              <td style="width: 25%; vertical-align: middle;">
                <div style="text-align: justify; font-weight: bold;">Utah</div>
              </td>
            </tr>
            <tr>
              <td style="width: 25%; vertical-align: middle;">
                <div style="text-align: justify;">129 W Trade Street, Suite 1405 </div>
                <div style="text-align: justify;">Charlotte, NC 28202</div>
              </td>
              <td style="width: 25%; vertical-align: middle;">
                <div style="text-align: justify; text-indent: -180pt; margin-left: 180pt;">279 West Main Street</div>
                <div style="text-align: justify; text-indent: -180pt; margin-left: 180pt;">Camden, TN 38320</div>
              </td>
              <td style="width: 25%; vertical-align: middle;">
                <div style="text-align: justify; text-indent: -180pt; margin-left: 180pt;">1080 Confroy Drive </div>
                <div style="text-align: justify; text-indent: -180pt; margin-left: 180pt;">South Boston, VA 24592</div>
              </td>
              <td style="width: 25%; vertical-align: middle;">
                <div style="text-align: justify;">1782 W 2300 S</div>
                <div style="text-align: justify;">West Valley City, UT 84119</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; font-weight: bold;">About IperionX </div>
      <div>&#160;</div>
      <div style="text-align: justify;">IperionX aims to become a leading American titanium metal and critical materials company &#8211; using patented metal technologies to produce high performance titanium alloys, from titanium minerals or scrap titanium, at
        lower energy, cost and carbon emissions. </div>
      <div>&#160;</div>
      <div style="text-align: justify;">Our Titan critical minerals project is the largest JORC-compliant mineral resource of titanium, rare earth and zircon minerals sands in the United States. </div>
      <div>&#160;</div>
      <div style="text-align: justify;">IperionX&#8217;s titanium metal and critical minerals are essential for advanced U.S. industries including space, aerospace, defense, consumer electronics, hydrogen, electric vehicles and additive manufacturing. </div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z87511c0da34742e982af59d7426fcea6" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 100%; vertical-align: top; background-color: rgb(217, 217, 217); border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="margin: 0px 0px 0px 6pt; font-style: italic; font-weight: bold; text-align: justify;">Forward Looking Statements</div>
              <div style="text-align: justify; font-style: italic; font-weight: bold;"> <br>
              </div>
              <div style="margin: 0px 6pt; font-style: italic; font-weight: normal; text-align: justify;">Information included in this release constitutes forward-looking statements. Often, but not always, forward looking statements can generally be
                identified by the use of forward-looking words such as &#8220;may&#8221;, &#8220;will&#8221;, &#8220;expect&#8221;, &#8220;intend&#8221;, &#8220;plan&#8221;, &#8220;estimate&#8221;, &#8220;anticipate&#8221;, &#8220;continue&#8221;, and &#8220;guidance&#8221;, or other similar words and may include, without limitation, statements regarding plans,
                strategies and objectives of management, anticipated production or construction commencement dates and expected costs or production outputs. </div>
              <div style="text-align: justify; font-style: italic; font-weight: bold;"><font style="font-weight: normal;"> <br>
                </font></div>
              <div style="margin: 0px 6pt; font-style: italic; font-weight: normal; text-align: justify;">Forward looking statements inherently involve known and unknown risks, uncertainties and other factors that may cause the Company&#8217;s actual results,
                performance, and achievements to differ materially from any future results, performance, or achievements. Relevant factors may include, but are not limited to, changes in commodity prices, foreign exchange fluctuations and general economic
                conditions, increased costs and demand for production inputs, the speculative nature of exploration and project development, including the risks of obtaining necessary licenses and permits and diminishing quantities or grades of reserves,
                the Company&#8217;s ability to comply with the relevant contractual terms to access the technologies, commercially scale its closed-loop titanium production processes, or protect its intellectual property rights, political and social risks,
                changes to the regulatory framework within which the Company operates or may in the future operate, environmental conditions including extreme weather conditions, recruitment and retention of personnel, industrial relations issues and
                litigation.</div>
              <div style="text-align: justify; font-style: italic; font-weight: bold;"> <font style="font-weight: normal;"><br>
                </font></div>
              <div style="margin: 0px 6pt; font-style: italic; font-weight: normal; text-align: justify;">Forward looking statements are based on the Company and its management&#8217;s good faith assumptions relating to the financial, market, regulatory and
                other relevant environments that will exist and affect the Company&#8217;s business and operations in the future. The Company does not give any assurance that the assumptions on which forward looking statements are based will prove to be correct,
                or that the Company&#8217;s business or operations will not be affected in any material manner by these or other factors not foreseen or foreseeable by the Company or management or beyond the Company&#8217;s control.<br>
                <br>
              </div>
              <div style="margin: 0px 6pt; font-style: italic; font-weight: normal; text-align: justify;">Although the Company attempts and has attempted to identify factors that would cause actual actions, events or results to differ materially from those
                disclosed in forward looking statements, there may be other factors that could cause actual results, performance, achievements, or events not to be as anticipated, estimated or intended, and many events are beyond the reasonable control of
                the Company. Accordingly, readers are cautioned not to place undue reliance on forward looking statements. Forward looking statements in these materials speak only at the date of issue. Subject to any continuing obligations under applicable
                law or any relevant stock exchange listing rules, in providing this information the Company does not undertake any obligation to publicly update or revise any of the forward-looking statements or to advise of any change in events,
                conditions or circumstances on which any such statement is based.</div>
              <div style="text-align: justify; font-style: italic; font-weight: bold;"><font style="font-weight: normal;"> </font><br>
              </div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image01.jpg
<TEXT>
begin 644 image01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  . )\# 2(  A$! Q$!_\0
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AT]JX.:%*HEC-=M]?3O==+='J^;XC>SG%^R_K^OZML?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image02.jpg
<TEXT>
begin 644 image02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" %_ J4# 2(  A$! Q$!_\0
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M<#%.%.X>S78U_P"W[O\ YYP?D?\ &C^WKO\ YYP?D?\ &LH"EQ1</9KL:O\
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M"Y3H?^$PU#_GC:_]\M_\51_PF&H?\\;3_OEO_BJYTC%)3Y8BL=#_ ,)EJ/\
MSQM/^^&_^*I#XSU'_GC:?]\M_P#%5SC"FFGRQ["L=)_PF>H_\\;3_OAO_BJ3
M_A--1_YXVG_?#?\ Q5<T:0T<L>P6.E_X374?^>-I_P!\-_\ %4G_  FVI?\
M/&S_ .^&_P#BJYK%-:CECV$=-_PF^I?\\+/_ +X;_P"*I/\ A-]2_P">%G_W
MPW_Q5<Q]::>*?+'L!U'_  G&I?\ /"S_ .^&_P#BJ3_A.=2_YX6?_?#?_%5R
MQIM'+'L(ZH^.M3_YX67_ 'PW_P 533X\U/\ YX67_?#?_%5RS"F$<57)'L!U
M9\>ZH/\ EA9?]\-_\533X^U3M!9?]\-_\57)TUNE')'L*[.M_P"$^U3_ )][
M+_OA_P#XJD_X3_5?^?>Q_P"^'_\ BJY$TE')'L)MG7'X@ZKC_CWL?^^'_P#B
MJ3_A8.J_\^]C_P!\/_\ %5R+"FT^2/8+LZ__ (6%JO\ S[V/_?#_ /Q5'_"P
MM5_Y]['_ +X?_P"*KCSTI,9HY(]@NSKS\0]6'_+O8_\ ?#__ !5'_"Q-6_Y]
M[#_OA_\ XJN.-(:.2/85V>^:3<O>:59W,H4230I(P7H"5!./SHJ#PY_R+VE_
M]>L7_H HKD>YH<[\1O\ F'_]M/\ V6N-P:[/XB#/]G_]M/\ V6N.K-[G;17N
M(2E!I12]:1I84&E!I,4N* 2'*:=G-,%.ICL.I13:>#2'RBXIU(*44!RB@4_
MI!3J Y1*<!2@4H%,.4!Q3J *7%*X^4*<* *<!3N+E!:D6F@4\4KCL+^%.Q2"
MG4PL+BEQ2K3P*5Q<HVE7WI^VEVTPY1  :6C%+C% <H 4M(#3C1<.4:!2XI>:
M6BX<HW%!%.I,T!RC<4FVGYI<B@7*1XH(XJ2DQZ4#Y2+;2%:DIIYH%RD6*3%2
M%:3%.XN4CP:3!/I4F*3;1<7*0D4F*E*TTBBX<I$136J1J:PIW$XD3"F$5(U-
M:G<EHB(II%2XII%5<FQ$13#4I&*813N+E&8I,8I^*2G<FQ&132*DIK"G<5AC
M#%,/-2$4W%-"L1XIN*DII&:+BL,-,Q4A&*0T[DM$=%*U-Q57$T(13#3FZTV@
MD;333C32:=P&FFFG-3#UHN(0TWM3LTP\T[@,-(:<32&G<5AE)3F--HN(;WI&
MYIQIIH 0\TVEI":8CW;PY_R+VE_]>L7_ * **/#G_(O:7_UZQ?\ H HKC>YH
M<[\13C^S_P#MI_[+7'"NP^(__,._[:?^RUQ@-9R>IZ%!>XB133QS40.33U.*
MFYMRCZ6F[J<#2N'*.Q2BDI0:+CL+BEQ0#3A2YA\H*#3J4"EQ1S!R@*>N*0"G
M8-*X^444ZFBG4<P<HHIRTT4]:.8?*.I:;FGJ:.8.444HI5IZT<P<HT4^EQ2X
MHY@Y1 :D#4W;2A?2CF#E)0:>N*B"D4X47#E)1BEQ48:GAJ.8.47;1LI0PI<T
M<P<HW%)BGYS2]*.87*,Q2$9I])1S!RC-M&VGT4<P^4CP:3D5+28]:.8.4CX-
M(13B/2D--2%RB8II%.I*.87*-*TWI4E(13YA<I'CBF-4C5&:=Q<I&1334AIK
M51+B1-3&J5JC847)Y1A'XTPT\\4PT[DM##S28I:0U5R;#2*0T$TE.XFA#TII
M]Z<>::U.XK"=*8U/)IIIIDM#<4TTI--)IDM#33:4TTFG<EH0TTFE-,/6G<5A
M&--I2*93N2T(U-IQ--HN)H:V>],-/-,-.XK"&D[4-3#[4[B TPTN:0F@!*2B
MFD^E.XA":0F@FFYHN)H6FYI2:9FF%CWGPW_R+NE_]>L7_H HH\-_\B[I?_7K
M%_Z **Y7N4<W\2#_ ,@[_MI_[+7%@^E=E\2_^8;_ -M/_9:XI36,MSTL.OW:
M)0<4X&HQ3P:BYO8>#3EIF:<#2;*L29S2@FF*:=NI7&D2 TY6%,%+2N.Q*#3P
M:A'%.!I-CL3K3@,FHE.:>*5QV) *=M&*C4T\-ZT7'RCMM. IH:EW8HN'*. S
M2@8H#"G@T<S'RB8^M.%. HI<P<H"I%.>M,Q3@*.8.4?3@<4S)I<T7#E),T[B
MHJ7-%Q6),4$4P-2AJ+BL/%+FFYHS1<5AV:7=3,T9IW"Q)D4G6F9I<TKBL.Z4
M4W-&:=PL.I,TF:,T7'86D---)FBX["TE(:3-/F#E%S32:0TQCBFF+E',U1DT
MA-(35ID<H-3":4FDS3YB>4:3332DBDR*I,3B-Q3&%/8TPTR7$813:>QIM,GE
M&$4PBI"13#33)Y1M-)I6IAIW): FF,?2E/6FFG<FPTTTT\U&35)DM"-33[TI
M-,8BG<AH,TTTA-(6IDV!N:::0M49-%Q6'$^E,+4A-,8TT*PI--+4A--S3)L*
M3FFFDS1FF)H;29H)ZTAHN2!-,-!-)3N &F]Z,TTGFF $TF:0FC/%,1[WX;_Y
M%W2_^O2+_P! %%'AK_D7-*_Z](O_ $ 45S/<9S/Q+_YAO_;3_P!EKB0<5VGQ
M-_YAO_;7_P!DKB 17//<];"K]VB8'-/J$,*>#BLSHY27%.''2H@?>G TKCL2
M#-/%1@TX-Q2*Y204_-1@BGBD.Q(/:EQ4=.4TKCY25<THS3 WK3MU*Y2B29I<
MTP-2@CTHN/E'@TM,!IX.:7,/E'!C3@3VIF*44N8.4EW-2AB*8&]:=N!HYA\H
M\24Y9*CR*7BBX6)@^:<&J &ES2N2XEC=1NJ '/0T[GUHYA<I+NI=U18]:,>]
M%Q<J)=]+OJ+\:7BG<5D2^91OJ+%&/2BX<J)MU&:@R12AJ+ARDVZC-0[J7=0+
ME)<XHW5%NII8T7#E)MU!:H-U)NIW'RD^ZD)J'-(210F/E)2U1DTPDTTY-7<3
M1(6Q320:C.::033)Y1Y:DW4RFYJDQ<HYFII:F[L=Z0L*I$\HN:0FDWBF-(*I
M$N(I-(33-XI&?-40T*332<4TM3<DTR6AY:HR::2:0YID- S4S=@T-FF&F0T*
MSTQGH(IAP*=R6A"V:86-..*:2*=R6AI-(30QII-,EH0TPFE9J835(AH#36-*
M3Q3,TQ :;FACVIA--$BDTA--+4W-,0YC3<TF::302QQ-,8TA;FD)IB FFYH+
M8IA- AQI,TPFFYI@?07AK_D7-*_Z](O_ $ 44>&/^1;TG_KTA_\ 0!16#W Y
M;XH'']F?]M?_ &2N%#UVWQ6;']E_]M?_ &2N"5ZYYK4]?"_PE_74M!J>&^E5
M0]/5ZBQU(M!J<&%5@].W5-AEH/ZTX,*K!C3@QI6&6@0:>K"JP<]J>K&D6BP#
M3JKAS3O,J;#2+'/K3@U5Q)3PXI:E6)LTY34(93UIP84BK$P-.!]ZB##UIRD>
MM2QV)E-.!J#Z-3@3ZTAV)@:=4()]:4$TKA8F I<>]1;FI0QIW%8EV^]&#ZTS
M=2[C2N*S'\T;S3-QHR:+A8D\PT>9[U%SZ4E,.5$WF4OF5!G%*&H%RE@2>]*)
M*K[O:C(]"*+BY"P9*3>*AW#U%&Z@.4FW#UHW5"6IN^@.4L;Z-_I4&_Z4FX>U
M,?(3[Z-QJ#(HR* Y2;<:0OS4.1ZTF15(+$Q>DWBH"U)FJL)HGWBD+CU%09IO
M!ZTTB6B5G7/WA3&(/\51Y%-W"J2):'D9_BIA7/\ %2%A32U6KD6'%<=\TW;2
M%J87-6B6A^*;32]-W52,VAY..]-)-,+4FZF2T/S36-,+8INZ@FPYC32::6IK
M-FFB&A2U,:FEZ87JK$-#LXZTQC36;)IA?TIV('DTS-(7IA:JL2QQ.::W%-WX
MZFFL^::('9IA--,E,+TR6.+4QC2%_4TPM0B1Q--+4PM3<U1(\OFFEO>F,?6F
M[J+"8_-&ZHBWH:;O--(DD+"FL]1EJ:6)IV >332U,+8IFZF(^C/"_P#R+.D_
M]></_H HI/"O_(L:1_UYP_\ H HKG>X'(?%QL?V3_P!M?_9*\^5Z[SXQ'']D
M?]MO_9*\Y#UFU=GJ8:5J:+@<4\/5,/[TX/2Y3HYRZK>]/#52$GH:>)/>I<31
M2+JO3M]4@_O3A)[U/*5S(O+)3Q+5%9*<']Z7(4I%Y9J?YV:SPY]:?OI<A2D7
MQ**7S*I!Z<&J>4KF+RO3@X]*H[J4.?6ERE)F@'%.WUGB0U(LIJ>0I2+RO3A(
M*I++3EEJ>1E)HO*X]:<']#5(2YIWF>]+D*NBZ)*7?5(2>]/$GO2Y!EO=2[JK
M+(/6GAQ4M!8F#FE\RH-P]:7</6E8.4G\RCS*@W4N:+!RDV_WHW>]0YQ1NIV#
ME)?QI<^]1%Q2;U]:=A6)MWO1NJ#>OK2&5119A9%C?2;Z@\U:0RK346*R)]XI
M"P/K4'FK2&0&J40)B1ZTW?4&ZDR:JQ+)S+BD\[VJ#)I-WL:I11.I.9<]!3#)
M4.ZC(JDD3J3>8?6D,GO4)(I,^]581+YE)YE1Y^E-II(ADN^D+U%FD)JK(EDO
MF4TR4S(II(II$,=OHWU'FD)IDLD+4TO49:D9J=B&2%Z:6J(L::S52B0V2%J;
MNJ(M32:JQFV3%J8S5$6(IC,:?*0V2E_I32U0EC3"U4D0V3%J86J$N::7-'*0
MY(E9A3"U1%Z:7JN4ALE)IA/%1%Z0O3L2V2-3"13"],9J$A7)"1ZTPD>M,W4F
M[-.Q%QS&F9II:FEJ8KCS2$U'NII:G80\M29J,MSUINZBPAY;FF%O6FEL]:8Q
MIV%<^E?"?_(K:/\ ]>4/_H HH\)?\BKHW_7E#_Z **Y7N4<1\:&Q_8__ &V_
M]DKS0/S7H_QM./[%_P"VW_M.O, U4HW1U4YVBD6M].#BJ@:G;J.0U54M^93@
M_O50-3@PI<A2J%S?3A)5,-3@V.]+D*54NB2G+)5(-3MU'(6JS+OFXIPEJEO]
MZ<KTO9HI5B\)A3A,/>J&ZG;J7LRU79?$PIXE%4-U*'J73+5<T!+3A+6?YE.$
MGO2]D6L0C0\T4X3>]9WF>].\SWH]D-5T:0EIWFUF^9[TH?WI>R+6(N:/F>]*
M)/>L_?[TX/[U/LQ^V- 2^].$WO6=O]Z4/[T>S&JYH^>?44OGGUK.W^]+O]Z7
MLD/VQH_:/7%+]IK.WCUHWCU%'L4/VYH_:12BX%9WF#UI?,'K2]D@]LS1^T+1
M]H2L_>*4.*/9(?M30^T)ZTTW">M4MZT;Q1[-![4N?:4[T?:$]*I[QZ4F\4_9
MH7M&73<)3?M([54W TA84U31/M67/M I//![U3W"DW"G[-$^U+GG>C4WSCZU
M5WK1O7UI\@O:>99\XTGG57+CUIN\>M-0)=0L^?2>>/2JVX>M-WBJ]F1[4M>=
M[4GG56WBDW57LT0ZI9\VD\RJVZDWT^1$^U+/F4A<56WT;_>GR$.H6-](9:K[
MJ0M5<A+J$WFBD\WTJ'--)]::@0ZA.9::9:@)]Z0FGR$NHR?S333)5??2%J?(
M0ZA,7II>H"],9J?(0ZA.STPN*A+TA;BGRD.9,9*8S@U"6INZGRD\Y*7II;/6
MHR:9NXI\I/.2EJ;FH]U-+4^4GF)"U,+5'NI"U%B6QY:FYIF^FEJ+!<=NINXT
MPFF[O2G85R3=3=U,+4PM1838\FD+4PM3=PHL(<332U-+4UFIV"Y].^$?^14T
M7_KRA_\ 18HH\(<^$]$_Z\8/_1:T5Q/<T.#^.!Q_8O\ VW_]IUY8#GO7J'QT
M./[$_P"V_P#[3KRL&MH+W2D[$V:4&H0:<#5!S$V:7-0@T[-%A\Y*&IX.*@#&
MG!O6BP^=DVZGAJKY]#3@?>CE'SE@/[TN^J^ZG9HY1^T)]].W8[U7!I0W-'*5
M[0L[J<&JL&I0U'(/VI9W4H857W?6EW4N4?M2SNI0U5@W%.5J.0/:ED-S3MXJ
ML&I=U'(5[8L!A3MU5MU*&HY ]L60U.W"JN^G;Z.0?MRR&%+N%5=YI=U'(/VY
M9WBC>*K;J7=2Y ]NRQO%+Y@JOOHWT<@_K!8\P4>8*K[Z7?1R![=ECS!1YE5]
MU&^CD'[<L>92^95;=2[Z/9A[<L;Q1O%0;J-V*.0/;D^\4;Q5?<:-V:.07MR?
M>*3<*A+49I\A/MB;=2;A46ZDW4^07MB;=1N%0[J3-'*+VI-N%&ZH=U)FGRB=
M5DV^DWU#N]:,^]/E)]HR7=2;ZBW4FZGRB]H2[J3=46ZDS3Y274)=U-WU&6I-
MU/E)YV2%J;N-1D\TF:+(7.QY:F[J:3[TTFBPN8>6IA;%-)IK-3L2Y#MQI":8
M6II8T6%<?NII:HR<4A-%A7'LU,+4UFIA:F%R0O3"U,S32:07'EJ0M49--S3)
MN/+4TM3"U(30*X\M32]1EOK32?2@+DA:FEJ8336:@5QY:FEL5&QIN:07'YQ3
M2U-)]Z:6IDW/J?P=_P BCHG_ %XP?^BUHI/!O_(H:'_UXP?^BUHK@>YT+8X#
MX[G']A_]M_\ VG7E(?-=[^TSX@L]"_X1O[;YG[XW.W8N>GE9_F*\5M?'6C3N
M5:66'T+IP?RK:#]T#KMU+NK)76M/*@_:XN>G/-/_ +8L0N3=1@=R3@5K8.9&
MJ&I=QK*CUK3W#%+R!@O4[QQ4L>IVD@S'<1N/56S18+HTMU+OK,35K%E#+=PD
M$X!#CKZ5!>>(=,LBHN+M%)Z <FBW<.9&V&IP:N2'C;3#!>2;B#;MM"DC]YZ$
M5BM\1#DE;>(+G !8DXQWJ;H+H])W4H;-<!#\1K%F8/;R* N5.<Y-13?$JW2,
M>59.\A7)^?"@^GK1S(+H]&S2AJ\Z'Q,M#;,QL9Q/V3<,'\:Q]>^(-W=K"NFA
MK-!S(=V68^F?2CGB',>OAJ7=7A%IXPU>&[^T&[D<ELD,<@CTQT[54F\1:EYE
MP4OK@)/G>I?U/3/IS2]H@YCZ#W4X&OGW2O%&IZ7(3!=RD$8V,^Y?R-;FB?$"
M\MKQ/MA,MN<[QG)Y/7\*?.@YCV?-.W5P]Q\1M#CC=HGGE=5RJ^7C<?3-8VJ?
M%%4<KIEF'0I]^5L$-]!5<R#F/4@U.W5XAI'Q$U&VU"2YU%GNH6'$ 8*JGVJM
M-\0];_M&6XAN<0L2%A9 55>WX^]+G0<Q[R&I=WKWKYZNO&6K75XMU/<-E9!*
MJ1G:JD#' ],5#-XJU'^T&NH+J9&^;9N?)4$8^E'.@YCZ(::-/OR(O^\P%2!@
M1D8(]J^7IM2NYVW37$SMG)+.235J'Q!JL,,4<5_<HD;;T"R$ 'UH]H'.?3(/
MI1G-?-4_B?69YUEEU.[+J<J?,(Q6TGQ&U]44+<)P,$L@8GWR:.=!SGOF:-U>
M%6_Q*UP29EEB=2A7!C P?[W'?_"JT7Q"\010F,7NXG'S.@9A^)%'.@YCW_-+
MFO![;XEZ\DI,DL$BG^%HA@?3%0+\0]?6,H;S*^I1=PYSUQ1SH.<]_P XI<UX
M-%\2=?CD+/-#(I.=K1# 'IQBI(/B;K:W"O*8)(]V6CV ;AZ9[4<Z'SGNN:,U
MY++\63M;RM, .T[=TF<-[^U95U\4]7>W"006L4G>0*3G\">*.9!SH]N+ #)(
M ]ZKW6H6=I#YMS=0Q1]F9P :^<[[Q7K-^C)=7\[JS;L9Q_+M[5F37UQ*L:RS
M2.L:[$!8G:N<X'XFESB]H>]W?Q"T"WEV+=&8 _,T8R!QV]:KQ?$K09+SR0TZ
MQD$^<Z +G'3KFO!"_O2,QQUJ>9BYV>UW'Q6TY+MTBM)I(!PKE@"QSSQZ8YI;
M/XK:7-?+#/:S00,<&8MNV^A(QTKQ$'UI>3THYF',SZ*OO'F@VUL)4O5N,MM*
M1<L/?!Q3F\=^'5CC<ZBGSX.T*21GU':OG8$A?>EWYS3YV'.SWS_A8_A_*!9Y
M#EL-E"-H]?>J<WQ2T99ML<-T\>1E]H'?GBO"]Q!ZTA;-+G8<[/HFS\>Z#<V[
MRM=^3L&61U^;'X9JE)\3- 63:K7+KS\XBP/U.:\%5\'BC?SUI\[#G9[K/\3M
M&614ACN)<@G<5"@'T.36II_CC0[NP%S)>Q6Q_BBE8!Q^ ZU\[>9_>I-^3P<4
M<[#F9]&Q^-O#TB%O[3A7 !(;(//M4<WCSP[$Z*=21MW.41F ^N!Q7SPLGK2A
MCNXYH]HQ<[/>O^%D>'=S#[1. IZ^2V#2?\+(\.[&;SY\@9V^2V37@K;L]>*0
MLRT>T8N9GO<7Q&\/R&,&>9"YP=T1^3W-=(NJV+0B47ML8R,AO,&"*^8M^:02
M$\'&!350?,SZ8GUW2X45I=1M%5NA,HYH_MK33-Y7V^U\S.-OFC.:^:-W/04X
M2_A3]H%V?4>?K36.*^;9/$.JR9#:C=$%=I!D/3TH&OZMO1O[1NBT?W,RGY?I
M3YT%V?2!IN:^=X_%&M))$XU.YS$"$)?.,]:U/^%@Z\RX-VH.,9$2_P"%/VB%
M<]T)IF:\6D^(VM26YBS;J2,>8J8;^?6J-OXTUN*=9!?2OM&-C_,K?44>TB*Y
M[JQII-><I\3K80_O;&7> OW7&"<<U9T/XBVE_=+;WMN;7><+)ORH^OI3YXWW
M'<[LFFEJP/\ A+M#+!1J,.2V._\ A5X:M8.H*7MLP/(Q*M5= 7R:;FJ$FJ6*
M#YKRW'UD%57\0Z4&(-_"2.#M)/\ *@FYK[J8360?$6E;@/ML?/?!Q3#XCTOG
M_2TX..A_PIV%S+N;):F;P2<'H<&LZ/6;"5=R7D!'NX'\Z:NK6(9\W< YS]\4
MK"NC2+"F$UC7GB+3K5@IG$A(R/+^;]:S)O&EE'_RRE(]R!0+F1U1;WII;Z5Q
M_P#PG5B2?W$N!R3N%+_PFMJX_=6\C<<_,.*+H&['6LW%-8UR8\9VP8;[>11Z
M[A4K>+]/Y.V8J.IVB@7,CI2:;N]Z\TU'QQ<22.EO^[BW$AD'S;>W7/-:&G^.
M;:/2X_M22O=*,$#^+WS4>TB5RL[DL#2$BO-+CQY>R(ZPP0Q'/RM]X_B*S;GQ
MEJTNW;<",J"/E4<TG6B'(S]!_!G_ ")^A?\ 7A!_Z+6BJ?PSF>X^&_A2:5MT
MDFDVCL?4F%":*Y'N="/!?VV/^9-_[??_ &A7S#DBOI_]M9'?_A#?+4G'VW/_
M ) KYA%O/_</YTTQ"K(ZX()&.G-/%U/M93(Y5NHSP:9]DG_N_K3OLD^.@_.G
MS,+#?,<=,BG^=(%PK,N>N#BD%G/VV_\ ?5/%C<GC"_\ ?5%PL$<SJN Y SG&
M>])-,[MN9BQ]2:D_L^YQSL'_  *FG3Y^[1_]]4*0K$)8G^(4F<=34W]GR=Y(
MA^-*+ ]3/&/SIW"Q!OQWI0P)&34_V'UG3\C2?8QWF'_?)I706(B_O2_7FI?L
MB=Y?_':>+2/O(_UVT70K:D&<?A2YS5A;:(#_ %CGT^4?XTHMD'W][?1MO]#0
MEV$4V!-(H8'DBM);6T_C6X'^[(#_ .RU/';Z3M'F)J/X/'5:CL9!#%N/QII4
M@]OSKH5M=#/\>HK]0K?RIWV#0C_R^7*_[\)_QIZCL<YM;V/XTNPULW=I8PR(
M+&?[0K*2V4*[3GCK4)A0_P (HLR?4S0K$8Z4S:QK3-O'_<% M8ST7'XT6871
MFE31M^7D\^U:36B'LWYTOV)3_>_.G9A=&:2H]_QI0 >AZ]*T?LF.A8?C2B)E
M_CS]0*5F%D9OU-230O"RK,K(64.N1U4]#]*TECDW JPX]4!'\J?.;R=D,DRG
MRT$:CRQPHZ"C4+(RX(1,[*'"D*6&1UP,U%C/0G\JV8S,G)\DGIGR_P#Z]-,D
MP^[Y?_?-+4++N9BHQ]2/I3[JW$<P$;,RE5;.WN0"1^=: N+H<!(#^!J3[5/_
M !VL#8]&(IZL&D9 C8CA')^E/^S2G^ CZUM"_/\ 'IZ'Z2G_  I?[3B'']DA
MO^V__P!:G9BT,9K-\\#(QFD-J_'R#\ZW%U6TW?/H[_\  9\_TJ3^UM,'WM(N
M?PD'^-'+YK\?\A7\C -DYZ;2?0$_X4GV9EC.Y<-VYX-=#_:^C=]*O ?][_Z]
M*NJ: >&TZZ'U_P#UU2I_WD'/Y,YK8!]Y>G6FLF"!CD^U=8FH>&SPUE,![J3_
M %J8:CX7)&8)!]4:G[+^\A<_DSC-HS]X8I\J)'+(H;<%8J&]>>M=G'>>%2?N
M1K_O*U6%N_"I;.^TY]<T_9?WD+G?9G >6#WS[4PKAL 8KTA;CPP>DEA^-6(W
M\/M]Q]//_ U%-4?[R%[1_P K/+Y(]IX.:38<^GXUZNL>BMT&G'_MHG^-2+9Z
M4_W8+!OHR'^M/V']Y![1_P K/)?+)I-AKV%-,L3]RRMC] IJ4:5;$<:?$?H@
MI_5_[R#VK_E9XTJ9/(XIS-CMCTKV8:5#VTY/^^!2_P!FQ#_F'I_WP*?U?^\B
M?:O^5GB^33L]L9S[5[/_ &>@_P"7&/\ []BE^QJ#_P >:8_ZYBCZK_>0>V?\
MK/%\@=!^5,Y)Z'\J]L^R*/\ ES7_ +]BD^S ?\N8_P"_8H^K?W@]L_Y6>,B(
ME,_,#]*:4;^ZWY5[3Y(Q_P >O_D.FB+'_+J?^_=/ZLOYA>V?\IXOY;GHC?\
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M515L4%LFGSRVN3R*][%Y=1E&-V#[D4KZE)T&!^%4#G%,Z=:.>7<.1=C274)
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MH<V,GU'\ZF/6HK[)LY0.3Q_.DQGH'Q?M+S5]8\$:9IT;375SHMHL40(!=RN
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M6HR0W$) R2K <,/:N"DC*G!&*T33U0B.@<T=*?&,FF(U] TJ74KR."%"SN<
M 5[3I/P5>]LF'VVT^V 9,"R@LOU':O)K:[GTCPIJFH63&.Y5%B21>J;S@D'L
M<9K@=$U:^TC58+_3[F6"[B<.LB,0<_6LW=O1E)'HGC+PI=^'=1>VNXRC*<<U
M=\):S+X>A6\L[*SN9,[6>YC,@3T&,BO7_C)&FO\ P]\/^(GC"W5U;HTA ZDJ
M":\)T;4?L-TR2()()/EDC;HPK&:E4@U%V9<;*5VM#TJ#XN:M)\DVAZ#./06K
M*?T:G-\3[1Q_I7@W27;N5D=/Z&N4TV_N_"FM6NM:)-NC5OD+#.0>L;CZ5]"6
M.N6?CWPRVH:)!9_VG"G^D6<T*.0?;(Y%>5&K54^23LSJG&"CS)71Y*OQ!\-2
MG_2O!D0]?*NC_45J:3;^!O';MI]A!/HNJN#Y*3N&20^@8=ZI:MXIBM+A[?4?
M#VDMM.U@;-%/Z 5Q6MZ?'$W]K:&66SWAB@/S6S>G^[Z&NB4ZU-<S=T9J-.>B
MT9G^-_"%YX=U*6VNX60H< XX(KC98RIY%?1WA7Q)I_Q&TE- \4O'%K<:[;2]
M;CSO16]Z\J\>>#KSP]J4MO<PE2IX.."*[J-=5%=&$Z;B[,X @T!<U:> @X(J
M6WLVD8!5YK>Z(L4XX2QXR:W?#_AN]U>=8K."21B<8"YKJ/#_ (4BCM#J.LR+
M::?'UD<<L?11W/M4>I>(II4.GZ#')96+,0%C_P!;-D\;B/\ T$<?6N:MB8T_
M4TITW/8Z"T^"GB":$-Y" D="XS3W^"?B)>EFS?3FJD/PO\7BSBO&M([82C<J
MS72128]P6!'XU(OA+X@VW%L]]M["VU$-_P"@O7/]:GNXFOL5_,1R_"'Q!$3N
MT^;_ +YJE-\+];0<V$W_ 'R:UH[;XIV9S%_PDH ]'=Q_,U2OO'OQ"TB807^L
M:K:RXW!+A "1ZX(I_6VMT+V#Z,Q+SX>:Q",M92@#_9KDM4TJXL9"L\;*1ZBO
M3+7XO>-HW4'4UN,G&V:W1\_I79?$ZU35/ASI>MZSIL6FZW< ^9$J[=PSPVWM
MD<XK2GB5-D3I..Y\U.N#3*L70 D(%5ZZS,0B@\4I&:;3&)1110 E%+24@"@T
M44!N?H=\+O\ DF?A'_L$6G_HE**7X7_\DS\)?]@BT_\ 1*45D6>#_MKJ2?!A
M Z?;?_:%?,9ARNY@/3-?57[8GG[O"'V=E7_C\SE0?^>%?-=Q937807,^X*<@
M<#%.PKF/)$8=NY",CJ13[:$SR!$&2>U;+:89DQ-<EE4<9?I45KIUJD2EY06(
MR>:+!<B_LB4?>>-/JP%":7$I_>7D0_X&*NK;6"]6!IP_LY/X<_A4V0&?=6MI
M')"5NHFRP#[<\#UIUQ9:;(S.MY,&/98B15XW%BO2+/XTJZE:KPL"CZT70SFS
M:2@_(C,,=<=:?:V;2KN\F4KCC''-;S:PD:$1VZMR>V*K6NL30Q;%B0<DY^IS
M1<0VTMO*49M'DD_O%\?RJWY4YZ6$8_WF)J)M9N#W J%M3F;^,_@:=_("U';7
M(0*(;8>Y6JMYH\URV\M"C>PP*B:^=OO.Q_&HFE##J?SH4O(!MOI,@N"))(MJ
MG!;=_2HY"%NGBZ[3U]:<"H.<G/N:AD/^G/Z%1_*JBP)6##J"!2?6HQ-(KE0Y
MVGM5Z&)9(06'/J*M:[$O0JTY6*]"14TMMM!(;CW%0F-]N[&5]1S5#T9(ERX]
M#4RW0_B7'TJF*7-&HK7+_GQMWJ>*3:RNAY!R#60:56(Z$CZ4"Y3L8/$NH1ZT
MVJO-YM^8S&)Y &905V\$].*QMQ+9)R>M9BW$@[Y^M2I=D?>7/TH22U!IFD'X
MIDN)(V5NC#!JNEU&W?'UJ3S%8<'-,DATW4?$.@#SM,N]2LHE; E@D=$S]1Q7
M7:5\;O'NG*(SKCW<8/*WD23Y_%AG]:S-&US4-)8FPNY8=W4(V ?K6W_PDUI>
M+MUG0]*OO5S;B-S_ ,"3!/XUC*/=%IG06?[0=Q*H77_">BWR]V@W0-_[,*W;
M'6_"7Q+T_4K71M*O-(UJTMFO$22421RA/O*/?!S^%>?2Z?X%U ?-9ZEILAY)
MM[@2*/\ @+C^M;/@^'PWX+&J:O8ZS<WU[):26MK;/;"/:9!M+,VXYP,\ =ZB
MT5MN#:,[X#)$WQLLEFC61=\WRL,@_(W:NJU3QIIESJ4Z:QX=T6^"NRYELTW8
MSZ@"L3X-:6^G^,9_%EU=6L6F:?'+*=TH$DCLA"HJ=3R>O2N+OKDS7DLG]YBU
M7RJ<A-G2Z]X<\,^(U:3PU%_8^HXR+9I"UO*?0$\H?Q(^E>7W5M-9W4EO=Q/%
M-$VUT88*D5U$-PT;;E."*NZY"/$=AYR@?VK;KP>\Z#^$^X[?EZ523CHP3[GL
M?ACP_H7@+X=+XK\,RRZQJ6H0^0;UP +,LOS*%'1NHR37A'C21I([&1SEF:4D
MG_@-=7\"_&*:3K$GAS6"9/#^M$6TZ-_RQD/"R#W!QGVK%^*VEOHNK_V;+]^U
MGFC/X%:F*M+4?4](4;OV;M&4'DSW8'UVUS?[+^&^*$:C[[65RJ_7RS70Z?*%
M_9^\.!L8.HW"G]*\Q^&NOGP7\1--U&7/EVMQLE'JAX;]*I:W0%_Q.CIK5V'S
MD2-G\ZR,GWKW_P"(OPNN=2U!]9\-Q_;=,O1Y\3Q'=@-S7F.I>!M7LL^=8SIC
MU0T1DK6):./W$=":<DK Y!-:$^CW,1PT3#ZBJILY5."IJ]!%_>;S0=1MI.08
M2ZY[,O(-5?@IJ+:7\4O#-RIQF]CC8C^ZYVM^A-7K.W:+2=2G<$)';.2?J,?U
MK ^&4+W'C_PY#$,N]_ H_P"^Q274I;'JWQPL5L=;\5H@PIRP'U(->/\ @6T2
M^\9:):2J&CFO88V![@N!7N'[0[!M>\38[1@']*\:^& S\1?#/_82M_\ T8M1
M3^$9[#^T!\.M,F\37<WA.WCM;Y%#RV,8"I-QR8QV;V[]N:^>5:2"8%=T<L;?
M0J1_(U]+?'74)+/XAW31N5*[2"#TXKS[Q'H%OXRMVO\ 2@D6OJN9(1PMY[CT
MD_\ 0OK1!M+4=]3O?A3\3M-\8Z3%X1^(,BBY"^79:E)U)Z!7/K[U@_$KX>7O
MAN^8/'O@8YCE4<,*\+99()F216CE0X8$8*D=J^A_@[\6K/4M.B\(?$%A+9L/
M+M;Z3DQ>BL?3WH:Y7S1$T>0SPM&V&&#38A\PKV/XH_#2XT*<W%J//L9/FCE3
MD$=J\EFMVAEVL,$&KC),EHV=4&/AUJ9_Z:0_^AUYK'RX^M>DZN<?#K4AZRP_
M^A5YM']\?6DMREL?9GCJ/'P-\,KUQ;1_^@"OF6[)68X]:^H/B(/+^#'AQ?\
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M6+_6+]:<'<25D?:?Q//_ !:#PZ/^G:+_ - %?+=]_K6SZU]/_%8D?"?PX/\
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MS%";B[H]?^$?Q);0)/[!\1@S:+*VS$@R8#_A5WXH_#K[!C5-%(N-.F^='3D
M&N#OHX/$EJ;RVVIJD:YD3H)P._\ O?SKKOA'\2/[&_XD/B3,^B3'8"_)@/\
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M&C]#_A;_ ,DR\(_]@>S_ /1*44?"W_DF7A'_ + ]G_Z)2BLBSP;]MG_F3/\
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M:  ]/2C-)1GM0 O7I2TW.!2Y]: '<8IN>>E&:.M "$TM)BG8H ;2T=*3'I0
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MSZ4 .S2=*,XZT4 &:7OQ2=NM&* #%+["DR<8&*.E !0:,FB@ R*,<']*._\
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MQ4T=\A^\"OZU862.4<%6HL"N4:*M2Q1 9.5^E1>3N^XP:@9%12LC+]X$4W-
M"TJC.[Z4E.7[K?2D!^C?PJ_Y)?X/_P"P-9_^B$HH^%7_ "2_P?\ ]@:S_P#1
M"45(SP;]MW_F2_\ M]_]H5\NCFOT(^*7PNT7XD_V9_;MSJ,']G^;Y7V.1$W>
M9LSNW(W]P8QCO7!?\,N^"C_S%/$?_@1!_P#&: /C,BEXK[+_ .&7?!7_ $%/
M$?\ X$0?_&:/^&7/!7_04\1_^!$'_P 9H ^-/TIN!GWK[,_X9<\%?]!3Q'_X
M$0?_ !F@?LM^"A_S%/$?_@1!_P#&: /C7(H[]Z^RA^RYX*'_ #%/$?\ X$0?
M_&:7_AEWP5_T$_$?_@1#_P#&: /C7'K^%!8XXX%?9/\ PRYX*_Z"GB/_ ,"(
M/_C-+_PRYX*_Z"GB/_P(@_\ C- 'QIVYHQZ5]E_\,N^"O^@IXC_\"(/_ (S2
M?\,N>"O^@IXC_P# B#_XS0!\;$4=J^RO^&7?!7_04\1_^!$'_P 9I#^RWX*/
M_,4\1_\ @1!_\9H ^-@?QI.E?97_  RYX*'_ #%/$?\ X$0?_&:/^&6_!6/^
M0IXC_P# B#_XS0!\:CZT-UZ5]E?\,M^"O^@IXC_\"(/_ (S2_P##+G@K_H*>
M(_\ P(@_^,T ?&G4\4M?97_#+G@K/_(4\1_^!$'_ ,9H_P"&7/!7_04\1_\
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M^-4*:L'*SY%/6DKZZ_X9J\'_ /02\0?]_P"'_P"-4?\ #-7@_P#Z"7B#_O\
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M(?\ P(A_^-4<Z#E9\<7IX7ZU5K[.D_9A\&28W:GXB_"XA_\ C5,_X9<\%?\
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/L510H+$ #.!S@"BI&?_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
